Presented Tuesday, June 14, 2022

Download this informative 1-hour presentation with insights into FDA GCP inspection trends, including intelligence on data integrity and clinical investigator enforcement activity. 

What will be covered:
  • Importance and challenges of human clinical studies 
  • Data sources and evaluation using AI Tools
  • What we can learn from US FDA Inspections of Clinical Investigators
  • A deeper dive into FDA Warning Letters and 483 data with some surprises

If you have any questions or comments, please do not hesitate to contact someone on our team at [email protected].